The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 203.00
Bid: 203.00
Ask: 204.00
Change: 1.00 (0.50%)
Spread: 1.00 (0.493%)
Open: 196.80
High: 204.50
Low: 192.00
Prev. Close: 202.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Louis Capital

31 Jul 2020 13:43

RNS Number : 8062U
TP ICAP PLC
31 July 2020
 

TP ICAP PLC

 

31 July 2020

 

TP ICAP plc announces the acquisition of Louis Capital Markets and MidCap Partners

 

Further to its announcement on 23 December 2019, TP ICAP plc ("TP ICAP") announces that it has today completed the acquisition of Louis Capital Markets and MidCap Partners (collectively "Louis Capital"), a private brokerage group specialising in equities and fixed income, primarily based in Europe.

 

Louis Capital operates in London and Paris, with other offices in New York and Hong Kong. The group has 80 front-office employees and specialises in cash equities and equity derivatives, fixed income and small cap advisory services. Michael Benhamou and Patrice Cohen who founded and led Louis Capital will remain as senior management.

 

Louis Capital will become part of TP ICAP's Global Broking division which provides high value inter-dealer broking services to top-tier banks in long-term established relationships. The acquisition builds on the successful acquisition track record of TP ICAP and will complement and strengthen the Group's offering in Continental Europe.

 

Transaction details:

 

The initial consideration paid for the acquisition was $21 million in cash (which is subject to adjustment based on the level of regulatory capital, working capital and net cash in Louis Capital as at today's date) with deferred non-contingent consideration of $6 million payable over two years. There is a further $17 million of deferred contingent consideration that may be payable dependent upon the performance of the business over three to five years. Finally, there is potential additional consideration via a profit share dependent upon the performance of the business. These subsequent payments will be satisfied through cash payments. TP ICAP expects the acquisition to be earnings accretive from the first year of acquisition on an underlying basis and from the second year on a reported basis.

 

Nicolas Breteau, CEO of TP ICAP, said, "The acquisition of Louis Capital demonstrates our growing appetite to complement our existing offering with high quality brands. Louis Capital's breadth of equity, equity derivatives and fixed income products will strengthen TP ICAP's position in Continental Europe."

 

ENDS

 

Enquiries:

 

TP ICAP:Analysts and investorsAl AlevizakosAlevizos.Alevizakos@tpicap.com+44 (0) 203 933 3040

 

MediaWilliam Baldwin-CharlesWilliam.Baldwin-Charles@tpicap.com+44 (0) 207 200 7124

 

About TP ICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 26 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQEAAXFDLFEEFA
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202411:00 amRNS2023 Annual Report and Notice of 2024 AGM
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202411:00 amRNSHolding(s) in Company
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20244:45 pmRNSDirector/PDMR Shareholding
4th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:45 pmRNSBlock Listing Application
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:01 amRNSLaunch of second share buyback programme of £30m
12th Mar 20247:00 amRNSFinal Results
31st Jan 20241:00 pmRNSHolding(s) in Company
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 202311:30 amRNSHolding(s) in Company
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20235:50 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 202310:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.